The Nikkei average is about 620 yen higher, with a backdrop of a weaker yen, testing higher levels in the market = 7 days ago.
On the 7th at around 10:04 AM, the Nikkei average was trading about 620 yen higher than the previous day at around 39,930 yen. At 9:54 AM, it reached a high of 40,700 yen and 58 sen, recovering to the 40,000 yen range for the first time since the year-end trading session. In the US stock market on the 6th, semiconductor-related stocks were in demand, leading to increases in the Nasdaq composite index and the SOX (Philadelphia Semiconductor Index). As a result, Japanese stocks saw buying activity, mainly in semiconductor-related sectors. The exchange rate has shifted to a weaker yen and in after-hours trading.
The Nikkei average fell sharply by 587 yen, with more than 70% of Main Board stocks declining = On the 6th, after the market opened in the afternoon.
On the 6th, after the market opened, the Nikkei Stock Average declined significantly by 587 yen and 49 sen to 39,307 yen and 05 sen during the afternoon session. The TOPIX (Tokyo Stock Price Index) also fell significantly by 28.54 points to 2,756.38 points. In the morning, the Nikkei Average started trading on a positive note, buoyed by the rise in US Stocks on the 3rd. However, it turned lower due to profit-taking selling and the drop in US stock index Futures during Extended hours trading. By 1:09 PM, the market remained weak, recording a drop of 661.
List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]
○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.
Sanyo Chemical Research Memo (7): Focus on new product development and new business creation with a Global Strategy.
As part of Sanyo Chemical Industries' <4471> mid-term growth Global Strategy, the company aims to contribute to sustainable economic growth and the resolution of social issues as a specialty chemical enterprise through its business, utilizing unique technologies and alliances. They are promoting new product development and the creation of new businesses, including functional proteins "Silk Elastin (R)" produced through Gene Editing technology, surgical hemostatic agents, agri-nutrition, and odor Sensors, following a blue ocean strategy.
List of breakout stocks (Part 1) [Ichimoku Kinko Hyo - List of breakout stocks]
○ List of stocks that have broken through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1379> Hokuto 1786 1759.5 1783 <1515> Nippon Steel Mining 448043654355 <1662> Petroleum Resources 112611201117.5 <1720> Tokyu Construction 720692.25708.5 <1721> Comsys HD 32253211.53194.5 <
Express News | Terumo Corp Says It Will Retire 10,137,600Treasury Shares on Jan 17
Announcements of individual stocks regarding the status of treasury stock acquisition, its completion, and the cancellation of treasury stock (PDF 96.13 KB)
Nikkei Average Contribution Ranking (Market Close) - The Nikkei Average has fallen for five consecutive days, with SoftBank Group and Tokyo Electron collectively lowering it by about 113 yen.
As of the close on the 19th, the number of rising and falling stocks in the Nikkei Average was 81 stocks up, 142 stocks down, and 2 stocks unchanged. The US stock market continued to decline on the 18th. The Dow Jones Industrial Average closed down 1,123.03 points at 42,326.87 dollars, while the Nasdaq closed down 716.37 points at 19,392.69 points. With a strong wait-and-see attitude ahead of the Federal Open Market Committee (FOMC) announcement, the market opened mixed after the opening.
The immediate stance is to Buy on dips [closing].
The Nikkei Average declined for five consecutive trading days, ending at 38,813.58 yen, down 268.13 yen (estimated Volume of approximately 2.2 billion shares). Following the perception that the results of the USA Federal Open Market Committee (FOMC) were hawkish, the major stock indices in the USA fell the previous day, leading to risk-averse selling. The Nikkei Average dipped to 38,355.52 yen shortly after the market opened. However, as the yen weakened to the mid-154 yen range against the dollar, it provided support for the market, while the Bank of Japan continued its financial measures.
Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings
The Nikkei average is down 132 yen, with a wait-and-see mood ahead of the U.S. price Indicators announcement.
The Nikkei Average is down 132 yen (as of 1:50 PM). In terms of contributions to the Nikkei Average, Advantest <6857>, SoftBank Group <9984>, and Tokyo Electron <8035> are among the top negative contributors, while Terumo <4543>, Sony Group Corp <6758>, and Kikkoman <2801> are among the top positive contributors. In the Sector, Pharmaceuticals, Glass & Ceramics Products, Mining, Wholesale Trade, and Marine Transportation are the top declining rates, while Insurance, Precision Instruments, Banking, Metal Products, and QITABANKUAI are among the top increases.
ADR Japanese stock ranking - Selling is generally dominant, especially for Japan Postal Bank ETC, with Chicago down 80 yen compared to Osaka at 39,320 yen.
Japanese stocks of American Depositary Receipts (ADR) fell compared to the Tokyo Stock Exchange (calculated at 151.94 yen per dollar), with notable declines in Japan Post Bank <7182>, Tokyo Electron <8035>, Mitsubishi Corporation <8058>, Advantest <6857>, SMC <6273>, Renesas <6723>, and Disco <6146>, indicating a general trend of selling. The Chicago Nikkei 225 Futures settlement price was down 80 yen at 39,320 yen compared to the Osaka day session. The U.S. stock market continued to decline, with the Dow Inc average decreasing by 154.10 dollars to 44,247.83 dollars.
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
JP Movers | Sumitomo Pharma Rose 6.07%, Leading Nikkei 225 Components, IHI Topped Turnover List
Market sentiment was stable today as Nikkei 225 components continued to trade sideways, with Sumitomo Pharma(4506.JP) being the top gainer today, rising 6.07% to close at 612.0 yen. In addition, the top loser was Fujikura(5803.JP),falling 5.45% to end at 5851.0 yen.
The Nikkei average is up by 165 yen, with attention on the U.S. CPI to be announced tomorrow evening, etc.
The Nikkei average is up by 165 yen (as of 14:50). In terms of contributions to the Nikkei average, Tokyo Electron <8035>, fanuc corp <6954>, and sony group corp <6758> are among the top positive contributors, while Fast Retailing <9983>, Terumo <4543>, and Chugai Pharmaceutical <4519> are among the top negative contributors. In the sector, iron & steel, wholesale trade, transportation equipment, electric appliances, and precision instruments have the highest rate of increase, while other products, insurance, nonferrous metals, pharmaceutical, and electric & gas industries are experiencing a decline.
The Nikkei average rose by 180 points, supported by stable china connect stocks in the Tokyo market.
The Nikkei average is up 180 yen (as of 13:50). In terms of contribution to the Nikkei average, Tokyo Electron <8035>, fanuc corp <6954>, and sony group corp <6758> are the top contributors, while Fast Retailing <9983>, Terumo <4543>, and Fujikura <5803> are the top negative contributors. In the sector, wholesale trade, iron & steel, transportation equipment, marine transportation, and electric appliances have the highest price increases, while other products, nonferrous metals, insurance, pharmaceuticals, and electric & gas industries are experiencing a decrease in value.
Terumo Buys Back 3.2 Million Shares in November
To promote the employment of people with disabilities, a new company called "Terumo Partners" has been established.
On December 4, 2024, Terumo Corporation (Headquarters: Shibuya, Tokyo; President: Mitsuyuki Samejima) established a new company called 'Terumo Partners Inc.' as part of its efforts to promote the employment of people with disabilities. The new company will establish systems and employment regulations that take into consideration the work environment of associates with disabilities, working towards creating a workplace where each individual can thrive in their own way. Additionally, Terumo Partners will subsequently work on "laws related to the promotion of the employment of persons with disabilities".
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Terumo has taken over and transferred the sales of seven pharmaceutical products from Kyowa Kirin Co., Ltd.
On December 2, 2024, Terumo Corporation (Headquarters: Shibuya, Tokyo, President: Mitsuaki Samejima) will inherit the manufacturing and sales approval for four products of dopamine hydrochloride injection "novan" from Kyowa Kirin Co., Ltd. (Headquarters: Chiyoda, Tokyo, President: Masashi Miyamoto) and will receive the transfer of sales for three products of diluted dobutamine hydrochloride injection "dobutamine." "Novan" and "dobutamine" are for use in the perioperative period (preoperative, intraoperative, and postoperative) for patients.